欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1866/001
药品名称
octaplasLG
活性成分
human plasma proteins 0.0 mg/ml
剂型
Solution for infusion
上市许可持有人
Octapharma AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Austria (AT)
Octaplas LG 45 - 70 mg/ml Infusionslösung
France (FR)
Spain (ES)
Norway (NO)
Poland (PL)
octaplasLG
Latvia (LV)
Octaplasma šķīdums infūzijām
Lithuania (LT)
octaplasma infuzinis tirpalas
Estonia (EE)
OCTAPLASLG
Hungary (HU)
OCTAPLASLG 45-70 mg/ml oldatos infúzió
Bulgaria (BG)
Czechia (CZ)
octaplasLG
Romania (RO)
OctaplasLG 45-70 mg/ml solutie perfuzabila
Croatia (HR)
octaplasLG 45-70 mg/ml otopina za infuziju
Malta (MT)
octaplasLG solution for infusion
Slovenia (SI)
Denmark (DK)
United Kingdom (Northern Ireland) (XI)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
Ireland (IE)
Finland (FI)
Slovakia (SK)
许可日期
2008/04/05
最近更新日期
2024/07/02
药物ATC编码
B05AA Blood substitutes and plasma protein fractions
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase